We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals

162 hedge funds and large institutions have $2.5B invested in Ironwood Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 54 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

17% more capital invested

Capital invested by funds: $2.14B → $2.5B (+$355M)

3.88% more ownership

Funds ownership: 127.53%131.42% (+3.9%)

2% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 54

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1% less funds holding

Funds holding: 163162 (-1)

22% less call options, than puts

Call options by funds: $2.28M | Put options by funds: $2.94M

Holders
162
Holders Change
-1
Holders Change %
-0.61%
% of All Funds
4.03%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
25
Increased
55
Reduced
54
Closed
18
Calls
$2.28M
Puts
$2.94M
Net Calls
-$656K
Net Calls Change
-$1.71M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$3.85M -$152K -11,104 -4%
USAA
52
United Services Automobile Association
Texas
$3.75M -$158K -11,582 -4%
Morgan Stanley
53
Morgan Stanley
New York
$3.71M -$4.28M -313,010 -55%
Swiss National Bank
54
Swiss National Bank
Switzerland
$3.5M +$39.2K +2,865 +1%
Fisher Asset Management
55
Fisher Asset Management
Washington
$3.46M
SEI Investments
56
SEI Investments
Pennsylvania
$3.43M +$532K +38,946 +19%
TRSOTSOK
57
Teachers Retirement System of the State of Kentucky
Kentucky
$3.39M -$259K -18,915 -7%
FAM
58
Fred Alger Management
New York
$3.19M +$3.05M +223,187 New
Renaissance Technologies
59
Renaissance Technologies
New York
$3.18M +$3.04M +222,625 New
GC
60
Guggenheim Capital
Illinois
$3.17M +$51.3K +3,755 +2%
Thrivent Financial for Lutherans
61
Thrivent Financial for Lutherans
Minnesota
$2.92M
Bank of America
62
Bank of America
North Carolina
$2.72M +$1.76M +128,384 +207%
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$2.57M +$108K +7,923 +5%
BCB
64
Brian C. Broderick
$2.46M
UONDDL
65
University of Notre Dame du Lac
Indiana
$2.44M +$2.34M +171,060 New
Millennium Management
66
Millennium Management
New York
$2.36M -$2.05M -149,970 -48%
WMSA
67
Weiss Multi-Strategy Advisers
New York
$2.13M +$65.3K +4,776 +3%
FHAM
68
Folger Hill Asset Management
New York
$2.13M +$2.04M +149,250 New
CEP
69
Chicago Equity Partners
Illinois
$2.09M -$236K -17,265 -11%
AA
70
ALPS Advisors
Colorado
$1.93M -$216K -15,771 -10%
American Century Companies
71
American Century Companies
Missouri
$1.88M +$1.8M +131,502 New
PIM
72
Platinum Investment Management
Australia
$1.78M -$255K -18,626 -13%
Manulife (Manufacturers Life Insurance)
73
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.72M +$198K +14,482 +14%
Bank of Montreal
74
Bank of Montreal
Ontario, Canada
$1.68M -$213K -15,571 -12%
Wells Fargo
75
Wells Fargo
California
$1.64M +$3.94K +288 +0.3%

IRWD Hedge Fund Activity: Q1 2017 in Review

162 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q1 2017, worth a combined $2.5B — up 17% from $2.14B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new IRWD positions and 18 closed out — a net gain of 7 holders — while 55 added to existing stakes and 54 trimmed.

The largest buyer was BlackRock, adding an estimated $185M. The largest seller was Janus Henderson Investors US, cutting an estimated $73.6M.

  • 162 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q1 2017, down from 163 in Q4 2016.
  • Funds reported $2.5B of Ironwood Pharmaceuticals stock for Q1 2017, up 17% quarter-over-quarter.
  • 25 funds opened new Ironwood Pharmaceuticals positions in Q1 2017 and 18 closed out, a net change of +7 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q1 2017 was BlackRock, an estimated $185M added.
  • The largest Ironwood Pharmaceuticals seller in Q1 2017 was Janus Henderson Investors US, an estimated $73.6M sold.

Based on aggregated 13F filings for Q1 2017.